1. Home
  2. PCRX vs EVER Comparison

PCRX vs EVER Comparison

Compare PCRX & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • EVER
  • Stock Information
  • Founded
  • PCRX 2006
  • EVER 2008
  • Country
  • PCRX United States
  • EVER United States
  • Employees
  • PCRX N/A
  • EVER N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • EVER Computer Software: Programming Data Processing
  • Sector
  • PCRX Health Care
  • EVER Technology
  • Exchange
  • PCRX Nasdaq
  • EVER Nasdaq
  • Market Cap
  • PCRX 1.2B
  • EVER 929.6M
  • IPO Year
  • PCRX 2011
  • EVER 2018
  • Fundamental
  • Price
  • PCRX $26.67
  • EVER $23.25
  • Analyst Decision
  • PCRX Buy
  • EVER Strong Buy
  • Analyst Count
  • PCRX 6
  • EVER 5
  • Target Price
  • PCRX $30.00
  • EVER $32.40
  • AVG Volume (30 Days)
  • PCRX 766.6K
  • EVER 490.9K
  • Earning Date
  • PCRX 08-05-2025
  • EVER 08-04-2025
  • Dividend Yield
  • PCRX N/A
  • EVER N/A
  • EPS Growth
  • PCRX N/A
  • EVER N/A
  • EPS
  • PCRX N/A
  • EVER 1.24
  • Revenue
  • PCRX $705,848,000.00
  • EVER $615,246,000.00
  • Revenue This Year
  • PCRX $7.36
  • EVER $32.27
  • Revenue Next Year
  • PCRX $10.07
  • EVER $11.05
  • P/E Ratio
  • PCRX N/A
  • EVER $18.69
  • Revenue Growth
  • PCRX 2.25
  • EVER 92.92
  • 52 Week Low
  • PCRX $12.61
  • EVER $16.63
  • 52 Week High
  • PCRX $27.64
  • EVER $30.03
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 67.86
  • EVER 45.21
  • Support Level
  • PCRX $25.14
  • EVER $22.37
  • Resistance Level
  • PCRX $27.04
  • EVER $23.90
  • Average True Range (ATR)
  • PCRX 0.78
  • EVER 0.75
  • MACD
  • PCRX 0.18
  • EVER 0.02
  • Stochastic Oscillator
  • PCRX 88.79
  • EVER 33.98

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Share on Social Networks: